pomalidomide,dexamethasone
bms
['pomalidomide', 'dexamethasone', 'multiple myeloma']
press release: positive early clinical data, inobrodib as monotherapy and +pom/dex. heavily pre-treated r/r multiple myeloma patients. #ash22 
Biotech CEO, Dir, Chair; CellCentric, Cyted, F2G, VaxEquity. Morningside Ventures. Prev. JIC, BBSRC, BIA.